| Variables |
All No.=87 |
Normal cytology No.=65 |
Abnormal cytology No.=22 |
p-value |
| Age AT enrollement years (min-max) |
46.00 (23-78) |
45.58 (23-78) |
46.41 (27-64) |
0.711 |
| Etnicity |
Italian |
65 (74.7%) |
47 (72.3%) |
18 (81.9%) |
0.546 |
| Other |
22 (25.3%) |
18 (27.7%) |
4 (18.1%) |
| History OF STD (except HIV) |
Yes |
63 (72.4%) |
45 (69.2%) |
18 (81.8%) |
0.098 |
| No |
24 (27.6%) |
20 (30.8%) |
4 (18.2%) |
| Time after HIV diagnosis years mean (min-max) |
7.19 (0-25) |
7.86 (0-25) |
5.54 (0-15) |
0.077 |
| Antiretroviral therapy |
Yes |
80 (92%) |
62 (95.4%) |
18 (81.8%) |
|
| No |
7 (8%) |
3 (4.6%) |
4 (18.2%) |
|
| Time after ARV beginning years (min-max) |
6.23 (0-25) |
6.83 (0-25) |
4.38 (0-13) |
0.055 |
| HIV-RNA<50 copies/mL |
54 |
42 |
12 |
1 |
| NADIR CD4 cell count mean cell/μL (min-max) |
279.51 (6-771) |
287.68 (7-740) |
255.41 (6-771) |
0.535 |
| LATEST CD4 cell count mean cell/μL (min-max) |
911.5 (95-1388) |
705.54 (95-1592) |
560.86 (173-1388) |
0.060 |
| AIDS defining condition |
19/87 (21.8%) |
12/65 (18.4%) |
7/22 (31.8%) |
0.095 |
| HR-HPV infection |
67/83 |
47 (56%) |
20 (24%) |
0.21 |
